ZA919884B - Azabicyclic amides or esters of halogenated benzoic acids - Google Patents

Azabicyclic amides or esters of halogenated benzoic acids

Info

Publication number
ZA919884B
ZA919884B ZA919884A ZA919884A ZA919884B ZA 919884 B ZA919884 B ZA 919884B ZA 919884 A ZA919884 A ZA 919884A ZA 919884 A ZA919884 A ZA 919884A ZA 919884 B ZA919884 B ZA 919884B
Authority
ZA
South Africa
Prior art keywords
azabicyclic
amides
esters
benzoic acids
halogenated benzoic
Prior art date
Application number
ZA919884A
Inventor
Francis David King
David King Francis
Original Assignee
Beecham Group Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Beecham Group Plc filed Critical Beecham Group Plc
Publication of ZA919884B publication Critical patent/ZA919884B/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D451/00Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
    • C07D451/02Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
    • C07D451/04Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof with hetero atoms directly attached in position 3 of the 8-azabicyclo [3.2.1] octane or in position 7 of the 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D451/00Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
    • C07D451/14Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing 9-azabicyclo [3.3.1] nonane ring systems, e.g. granatane, 2-aza-adamantane; Cyclic acetals thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D453/00Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
    • C07D453/02Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
ZA919884A 1990-12-19 1991-12-17 Azabicyclic amides or esters of halogenated benzoic acids ZA919884B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB909027487A GB9027487D0 (en) 1990-12-19 1990-12-19 Pharmaceuticals

Publications (1)

Publication Number Publication Date
ZA919884B true ZA919884B (en) 1992-10-28

Family

ID=10687217

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA919884A ZA919884B (en) 1990-12-19 1991-12-17 Azabicyclic amides or esters of halogenated benzoic acids

Country Status (13)

Country Link
EP (1) EP0563087A1 (en)
JP (1) JPH06503332A (en)
KR (1) KR930703308A (en)
AU (1) AU9053391A (en)
CA (1) CA2098729A1 (en)
GB (1) GB9027487D0 (en)
IE (1) IE914395A1 (en)
MX (1) MX9102630A (en)
NZ (1) NZ241019A (en)
PT (1) PT99831A (en)
TW (1) TW226020B (en)
WO (1) WO1992011259A1 (en)
ZA (1) ZA919884B (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9214184D0 (en) * 1992-07-03 1992-08-12 Smithkline Beecham Plc Pharmaceuticals
GB9721139D0 (en) 1997-10-07 1997-12-03 Glaxo Group Ltd Medicaments
WO2002016357A2 (en) * 2000-08-18 2002-02-28 Pharmacia & Upjohn Company Quinuclidine-substituted aryl moieties for treatment of disease (nicotinic acetylcholine receptor ligands)
WO2002016356A2 (en) * 2000-08-18 2002-02-28 Pharmacia & Upjohn Company Quinuclidine-substituted aryl moieties for treatment of disease (nicotinic acetylcholine receptor ligands)
US6492385B2 (en) 2000-08-18 2002-12-10 Pharmacia & Upjohn Company Quinuclidine-substituted heteroaryl moieties for treatment of disease
EP1381603A2 (en) 2000-08-18 2004-01-21 PHARMACIA &amp; UPJOHN COMPANY Quinuclidine-substituedaryl moieties for treatment of disease ( nicotinic acetylcholine receptor ligands )
WO2002017358A2 (en) 2000-08-21 2002-02-28 Pharmacia & Upjohn Company Quinuclidine-substituted heteroaryl moieties for treatment of disease (nicotinic acetylcholine receptor antagonists)
US6599916B2 (en) 2000-08-21 2003-07-29 Pharmacia & Upjohn Company Quinuclidine-substituted heteroaryl moieties for treatment of disease
PE20021019A1 (en) 2001-04-19 2002-11-13 Upjohn Co SUBSTITUTED AZABYCLE GROUPS
WO2003070728A2 (en) 2002-02-15 2003-08-28 Pharmacia & Upjohn Company Azabicyclo-substituted benzoylamides and thioamides for treatment of cns-related disorders
US7176198B2 (en) 2002-08-01 2007-02-13 Pfizer Inc. 1H-pyrazole and 1H-pyrrole-azabicyclic compounds for the treatment of disease
TW200842733A (en) 2007-04-17 2008-11-01 Univ Nat Chiao Tung Object image detection method

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2476088A2 (en) * 1979-01-16 1981-08-21 Delalande Sa NOVEL NOR-TROPANE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION
FR2529548A1 (en) * 1982-07-02 1984-01-06 Delalande Sa NOVEL DERIVATIVES OF AMINO-3 QUINUCLIDINE, THEIR PROCESS AND THEIR THERAPEUTIC APPLICATION
EP0220011A3 (en) * 1985-10-12 1990-01-03 Beecham Group Plc Use of azabicloalkylbenzamides in the treatment of gastrointestinal motility disorders, migraine, emesis, cluster headaches, trigeminal neuralgia and arrhythmia
GB8829079D0 (en) * 1988-12-13 1989-01-25 Beecham Group Plc Novel compounds

Also Published As

Publication number Publication date
MX9102630A (en) 1992-06-01
KR930703308A (en) 1993-11-29
JPH06503332A (en) 1994-04-14
NZ241019A (en) 1994-07-26
GB9027487D0 (en) 1991-02-06
TW226020B (en) 1994-07-01
CA2098729A1 (en) 1992-06-20
IE914395A1 (en) 1992-07-01
PT99831A (en) 1992-12-31
EP0563087A1 (en) 1993-10-06
WO1992011259A1 (en) 1992-07-09
AU9053391A (en) 1992-07-22

Similar Documents

Publication Publication Date Title
EP0535825A3 (en) Process for the purification of carboxylic acids and/or their anhydrides
HU9300776D0 (en) Carboxylic acid esters of rapamycine
HU9301710D0 (en) Copoliamides of terephthalic acid
HK1007742A1 (en) Purification of fluorinated carboxylic acids
EP0462776A3 (en) Preparation of optically active aliphatic carboxylic acids
PT76937B (en) Process for the preparation of piperidyl esters and/or n-piperydilamides of substituted benzoic acids or dicarbocyclic or heterocyclic carboxylic acids
EP0485157A3 (en) Esters and amides of substituted pyrrole acetic acids
ZA913123B (en) Isoquinoline amides and esters as 5-ht3recepto antagonists
EP0485158A3 (en) Esters and amides of substituted phenyl acetic acids
EP0485172A3 (en) Esters and amides of substituted indenyl acetic acids
EP0418667A3 (en) Carboxylic acid amides
ZA937474B (en) Quinolonecarboxylic acids
ZA919884B (en) Azabicyclic amides or esters of halogenated benzoic acids
ZA908757B (en) Pesticidal pyrimidinyl benzoic acids and esters
EP0442448A3 (en) Heterocyclic carboxylic acids and esters
EP0464381A3 (en) 2-methoxyiminocarboxylic acid esters
ZA938988B (en) Substituted benzoic acids
HU913298D0 (en) Process for the extraction of iodine compounds from carbonic acids and/or anhydrides
DE3460967D1 (en) Process for the preparation of carboxylic acids and/or esters
ZA903242B (en) Stabilization of carboxyl esterase
DE59305738D1 (en) Process for the preparation of halogenated benzoic acids
KR960009136B1 (en) Display monitor
IE901586L (en) Esters of 2 halo-propionic acids
CS233890A3 (en) Algicide of the type n-ethyl-2-pyrrolidinylmethyl esters of alkoxycarbanilic acids
ZA874941B (en) 7beta-(substituted)amino-3-substituted cephalosporanic acids and esters